ARGX — argenx SE Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareBalancedLarge CapNeutral
- $22.34bn
- $20.16bn
- $410.75m
- 52
- 10
- 73
- 41
Annual cashflow statement for argenx SE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | -96.5 | -199 | -478 | -349 | -720 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 22.6 | 43.1 | 94.1 | 93.5 | 154 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 9.85 | 305 | -18.8 | -357 | -401 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -63.5 | 152 | -398 | -607 | -863 |
| Capital Expenditures | -0.807 | -46.7 | -5.14 | -121 | -104 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -126 | -787 | 350 | -226 | -357 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -127 | -833 | 345 | -347 | -461 |
| Financing Cash Flow Items | -15.7 | -25.7 | -0.545 | 0.438 | -0.371 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 289 | 734 | 833 | 1,121 | 844 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 106 | 50.4 | 845 | 118 | -534 |